Average one-year price target for Lipocine (LPCN) was raised to $13.26/share, a 19.54% increase from the prior $11.09 target dated Feb 21, 2026. The figure is an average of multiple analyst targets and reflects a modestly bullish revision to street expectations rather than a material change to company fundamentals; likely to have limited near-term market impact.
Average one-year price target for Lipocine (LPCN) was raised to $13.26/share, a 19.54% increase from the prior $11.09 target dated Feb 21, 2026. The figure is an average of multiple analyst targets and reflects a modestly bullish revision to street expectations rather than a material change to company fundamentals; likely to have limited near-term market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.30
Ticker Sentiment
